Zydus Lifesciences to launch Semaglutide Injection in India after patent expiry EP News Bureau Feb 26, 2026 Company plans rollout under SEMAGLYN, MASHEMA and ALTERME brands with adjustable single-pen device
Lupin signs exclusive agreement with Gan & Lee for Bofanglutide in India EP News Bureau Dec 30, 2025 Agreement covers licensing, supply, and distribution of fortnightly GLP-1 therapy
